Outcomes to adverse event, date of event, implant date: estimated dates.Unique device identifier (udi#): in the absence of a reported part number, the udi cannot be calculated.The device was not returned for evaluation.A review of the lot history record could not be conducted because the part and lot number was not provided.The reported patient effect of death is listed in the xience xpedition everolimus eluting coronary stent systems instructions for use as a known patient effect of coronary procedures.A conclusive cause for the reported death and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.The additional patient effects referenced are being filed under a separate medwatch report number.
|
It was reported in a research article that xience xpedition stents may be related to death, in-stent restenosis, target lesion failure, hospitalization and repeat revascularization.Specific patient and procedural information is not known.Additional.
|